Clinical trials
Phase 2/3 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 1 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 14 |
| Unknown status | 8 |
| Terminated | 6 |
| Active, not recruiting | 6 |
| Enrolling by invitation | 3 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 14 |
| Chinese University of Hong Kong | 9 |
| Bristol-Myers Squibb | 4 |
| Hoffmann-La Roche | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| ASLAN Pharmaceuticals | 2 |
| Amgen | 2 |
| NRG Oncology | 2 |
| Novartis Pharmaceuticals | 2 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Angioedemas, Hereditary | 2 |
| Anxiety Disorders | 2 |
| Breast Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Hepatocellular | 2 |
| Depressive Disorder | 2 |
| Diabetic Nephropathies | 2 |
| Glomerulonephritis, IGA | 2 |
Trials
Showing 51 to 72 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.